Nucleic acid-containing amyloid fibrils potently induce type I interferon and stimulate systemic autoimmunity
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nucleic acid-containing amyloid fibrils potently induce type I interferon and stimulate systemic autoimmunity
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 109, Issue 36, Pages 14550-14555
Publisher
Proceedings of the National Academy of Sciences
Online
2012-08-18
DOI
10.1073/pnas.1206923109
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Protein-DNA Interaction at the Origin of Neurological Diseases: A Hypothesis
- (2017) Juan S. Jiménez JOURNAL OF ALZHEIMERS DISEASE
- Modulation of T-cell function by type I interferon
- (2012) David F Tough IMMUNOLOGY AND CELL BIOLOGY
- Peptides Released by Physiological Cleavage of Semen Coagulum Proteins Form Amyloids that Enhance HIV Infection
- (2011) Nadia R. Roan et al. Cell Host & Microbe
- Membrane and surface interactions of Alzheimer’s Aβ peptide - insights into the mechanism of cytotoxicity
- (2011) Thomas L. Williams et al. FEBS Journal
- Pathogen Recognition by the Innate Immune System
- (2011) Himanshu Kumar et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Binding with Nucleic Acids or Glycosaminoglycans Converts Soluble Protein Oligomers to Amyloid
- (2011) Jeremy Di Domizio et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genomics and the Multifactorial Nature of Human Autoimmune Disease
- (2011) Judy H. Cho et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutrophils Activate Plasmacytoid Dendritic Cells by Releasing Self-DNA-Peptide Complexes in Systemic Lupus Erythematosus
- (2011) R. Lande et al. Science Translational Medicine
- Netting Neutrophils Are Major Inducers of Type I IFN Production in Pediatric Systemic Lupus Erythematosus
- (2011) G. S. Garcia-Romo et al. Science Translational Medicine
- Biochemical and biophysical features of both oligomer/fibril and cell membrane in amyloid cytotoxicity
- (2010) Massimo Stefani FEBS Journal
- Protein folding: The dark side of proteins
- (2010) Jim Schnabel NATURE
- Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes
- (2010) Seth L Masters et al. NATURE IMMUNOLOGY
- Slc15a4, AP-3, and Hermansky-Pudlak syndrome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells
- (2010) A. L. Blasius et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identifying the amylome, proteins capable of forming amyloid-like fibrils
- (2010) Lukasz Goldschmidt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bifurcation of Toll-Like Receptor 9 Signaling by Adaptor Protein 3
- (2010) M. Sasai et al. SCIENCE
- Deficiency of Type I IFN Receptor in Lupus-Prone New Zealand Mixed 2328 Mice Decreases Dendritic Cell Numbers and Activation and Protects from Disease
- (2009) H. Agrawal et al. JOURNAL OF IMMUNOLOGY
- Induction of autoimmunity by pristane and other naturally occurring hydrocarbons
- (2009) Westley H. Reeves et al. TRENDS IN IMMUNOLOGY
- Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE
- (2008) Vilma Urbonaviciute et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The innate immune system in SLE: type I interferons and dendritic cells
- (2008) L Rönnblom et al. LUPUS
- The NALP3 inflammasome is involved in the innate immune response to amyloid-β
- (2008) Annett Halle et al. NATURE IMMUNOLOGY
- EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
- (2008) Dagmar E Ehrnhoefer et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More